Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba Capsule for Visual Function in POAG
NCT04334564Unknown
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Apr 2015
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ginkgo biloba extract in primary open-angle glaucoma (POAG) (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Mean Defect of Visual Field at 48 weeks. Status: unknown.
02
Drugs
ginkgo biloba extract
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT04334564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04334564.